Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

14 results
Display

LAMC1 is a prognostic factor and a potential therapeutic target in endometrial cancer

Kunitomi H, Kobayashi , Wu RC, Takeda T, Tominaga E, Banno K, Aoki D

OBJECTIVE: With the emerging significance of genetic profiles in the management of endometrial cancer, the identification of tumor-driving genes with prognostic value is a pressing need. The LAMC1 gene, encoding...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Screening for Lynch syndrome using risk assessment criteria in patients with ovarian cancer

Takeda T, Tsuji K, Banno K, Yanokura M, Kobayashi , Tominaga E, Aoki D

OBJECTIVE: Lynch syndrome is a cancer predisposition syndrome caused by germline mutation of DNA mismatch repair (MMR) genes. Lynch syndrome only causes about 0.4% of cases of ovarian cancer, which...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy and safety of adding mizoribine to standard treatment in patients with immunoglobulin A nephropathy: A randomized controlled trial

Hirai K, Ookawara S, Kitano T, Miyazawa H, Ito K, Ueda Y, Kaku Y, Hoshino T, Mori H, Yoshida I, Kubota K, Yamaji Y, Takeda T, Nakamura Y, Tabei K, Morishita

BACKGROUND: Mizoribine (MZR) is an immunosuppressive drug used in Japan for treating patients with lupus nephritis and nephrotic syndrome and has been also reportedly effective in patients with immunoglobulin A...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Risedronate on Osteoarthritis of the Knee

Iwamoto J, Takeda T, Sato Y, Matsumoto

The purpose of the present study was to discuss the effects of risedronate on osteoarthritis (OA) of the knee by reviewing the existing literature. The literature was searched with PubMed,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of the Effects of Alendronate and Alfacalcidol on Hip Bone Mineral Density and Bone Turnover in Japanese Men Having Osteoporosis or Osteopenia with Clinical Risk Factors for Fractures

Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto

PURPOSE: The comparative effects of alendronate and alfacalcidol on bone mineral density (BMD) and bone turnover have already been established in postmenopausal women with osteoporosis. An open-labeled prospective study was...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Influence of Ovariectomy on Bone Turnover and Trabecular Bone Mass in Mature Cynomolgus Monkeys

Iwamoto J, Seki A, Matsuura M, Sato Y, Takeda T, Matsumoto , Yeh JK

PURPOSE: To examine the influence of ovariectomy (OVX) on bone turnover and trabecular bone mass at the 3 clinically important skeletal sites in mature cynomolgus monkeys. MATERIALS AND METHODS: Six...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Effects of Alendronate and Raloxifene on Lumbar Bone Mineral Density, Bone Turnover, and Lipid Metabolism in Elderly Women with Osteoporosis

Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto

  • KMID: 2396095
  • Yonsei Med J.
  • 2008 Feb;49(1):119-128.
PURPOSE: To compare the effects of alendronate and raloxifene on lumbar bone mineral density (BMD), bone turnover, and lipid metabolism in elderly women with osteoporosis. Subjects and Methods: One hundred...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Vitamin K2 on the Development of Osteopenia in Rats as the Models of Osteoporosis

Iwamoto J, Takeda T, Sato Y

Vitamin K2 is widely used for the treatment of osteoporosis in Japan. To understand the effects of vitamin K2 on bone mass and bone metabolism, we reviewed its effects on...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Effect of Treatment with Etidronate and Alendronate on Lumbar Bone Mineral Density in Elderly Women with Osteoporosis

Iwamoto J, Takeda T, Sato Y, Uzawa M

  • KMID: 2428289
  • Yonsei Med J.
  • 2005 Dec;46(6):750-758.
The purpose of this open-labeled prospective study was to compare the treatment effects of cyclical etidronate and alendronate on the lumbar bone mineral density (BMD), bone resorption, and back pain...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prevention and Treatment of Corticosteroid-Induced Osteoporosis

Iwamoto J, Takeda T, Sato Y

Osteoporosis is one of the most serious complications of corticosteroid treatment. Loss of bone mineral density (BMD) and fractures occur early in the course of corticosteroid treatment, and thus early...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of Oral Etidronate for Skeletal Diseases in Japan

Iwamoto J, Takeda T, Sato Y

Etidronate is an oral bisphosphonate compound that is known to reduce bone resorption through the inhibition of osteoclastic activity. The efficacy of etidronate for involutional (postmenopausal and senile) and glucocorticoid-induced...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Determinants of One-year Response of Lumbar Bone Mineral Density to Alendronate Treatment in Elderly Japanese Women with Osteoporosis

Iwamoto J, Takeda T, Sato Y, Uzawa M

The purpose of this study was to determine factors that could predict the one-year response of the lumbar bone mineral density (BMD) to alendronate treatment in elderly Japanese women with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Differential Effect of Vitamin K and Vitamin D Supplementation on Bone Mass in Young Rats Fed Normal or Low Calcium Diet

Iwamoto J, Takeda T, Ichimura S, Sato Y, Yeh JK

  • KMID: 2428329
  • Yonsei Med J.
  • 2004 Apr;45(2):314-324.
The purpose of this study was to clarify the differential effect of vitamin K and vitamin D supplementation on bone mass in young rats fed a normal or low calcium...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Combined Treatment with Vitamin K2 and Bisphosphonate in Postmenopausal Women with Osteoporosis

Iwamoto J, Takeda T, Ichimura S

  • KMID: 2428340
  • Yonsei Med J.
  • 2003 Oct;44(5):751-756.
Vitamin K2, as well as bisphosphonates, such as etidronate, alendronate, and risedronate, is widely used in the treatment with osteoporosis in Japan. Etidronate increases the lumbar bone mineral density (BMD),...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr